Dr. Jae-Gook Shin
Professor and Chair of the Department of Pharmacology and Clinical Pharmacology, and Founding Director of the Pharmacogenomics Research Center at Inje University College of Medicine
Dr. Jae-Gook Shin is currently a Professor and Chair of the Department of Pharmacology and Clinical Pharmacology, and Founding Director of the Pharmacogenomics Research Center at Inje University College of Medicine, Busan, Korea. He is also Director of the Center for Personalized Precision Medicine of Tuberculosis (cPMTb) at Inje University College of Medicine, which is funded by Korean Ministry of Science and ICT. He has been served for the clinical trial center, global center of excellence in clinical trials in Inje University Busan Paik hospital. Dr. Shin is working for SPMED Co., a bioventure for personalized precision medicine based on pharmacogenomics, as a CEO since last year.
Dr. Shin received his Ph.D. in Pharmacology from Seoul National University School of Medicine in 1992, and MD degree from Inje University College of Medicine in 1986. Dr. Shin completed 2 years Clinical Pharmacology fellow training in the Division of Clinical Pharmacology at Georgetown University Medical Center, in Washington DC as a 1997 recipient of the Merck Sharp & Dohme International Fellowship in Clinical Pharmacology funded by the Merck Foundation.
Dr. Shin has published over 320 papers in the peer reviewed international journals including Pharmacogenomics and personalized medicine, clinical PK/PD, DMPK and drug interaction, PK/PD modeling, and other clinical pharmacology areas. He has been served as editorial board members for several renowned international journals including Clinical Pharmacology and Therapeutics(CP&T), British Journal of Clinical Pharmacology (BJCP), Pharmacogenetics and Genomics, Pharmacogenomics J, Personalized Medicine, etc. Dr. Shin has been served as Chair of the Organizing Committee for several national and international meetings, including the International Symposia on Pharmacogenomics and the 11th International ISSX meeting. Dr. Shin has also served for many academic societies and national/regional committees as Chair and/or Member of the IUPHAR Clinical Pharmacology Council and Pharmacogenetics Committee, the Korean Association of Clinical Trial Centers, the Korean Network of South-Eastern Regional Clinical Trial Organization, and Korean National Enterprise for Clinical trials etc. Dr. Shin has received several awards including the Pfizer Medical Research awarded by the National Academy of Medicine of Korea.
Currently, he is highly interested to the model informed precision dosing (MIPD) with using population and PBPK modeling, especially for the antituberculosis drugs. Therefore, he is looking for the global collaborators who may contribute to the eradication of tuberculosis with using MIPD approaches.
